Proteins > Casein kinase II subunit alpha 3
Page last updated: 2024-08-08 00:38:06
Casein kinase II subunit alpha 3
A protein that is a translation product of the CSNK2A3 gene in human. [PRO:DNx, UniProtKB:Q8NEV1]
Synonyms
CK II alpha 3;
EC 2.7.11.1;
Casein kinase II alpha 1 polypeptide pseudogene
Research
Bioassay Publications (14)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 6 (42.86) | 2.80 |
Compounds (22)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
4,5,6,7-tetrabromo-2-azabenzimidazole | Homo sapiens (human) | IC50 | 0.8667 | 3 | 3 |
4,5,6,7-tetrabromo-2-azabenzimidazole | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
chromone-2-carboxylic acid | Homo sapiens (human) | IC50 | 5.9800 | 1 | 1 |
emodin | Homo sapiens (human) | Ki | 1.9000 | 1 | 1 |
mitoxantrone | Homo sapiens (human) | IC50 | 0.6600 | 1 | 1 |
boldine | Homo sapiens (human) | IC50 | 0.7000 | 1 | 1 |
purvalanol b | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
purvalanol a | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
4,5,6,7-tetrabromobenzimidazole | Homo sapiens (human) | IC50 | 0.9300 | 1 | 1 |
quercetin | Homo sapiens (human) | IC50 | 0.5500 | 1 | 1 |
quercetin | Homo sapiens (human) | Ki | 1.1800 | 1 | 1 |
apigenin | Homo sapiens (human) | IC50 | 0.8000 | 1 | 1 |
luteolin | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
kaempferol | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
baicalein | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
chrysin | Homo sapiens (human) | IC50 | 9.0000 | 1 | 1 |
fisetin | Homo sapiens (human) | IC50 | 0.3500 | 1 | 1 |
morin | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
myricetin | Homo sapiens (human) | IC50 | 0.9000 | 1 | 1 |
coumestrol | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
coumestrol | Homo sapiens (human) | Ki | 7.6700 | 1 | 1 |
casein kinase ii | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
casein kinase ii | Homo sapiens (human) | Ki | 0.0400 | 1 | 1 |
cx 4945 | Homo sapiens (human) | IC50 | 2.2013 | 5 | 5 |
cx 4945 | Homo sapiens (human) | Ki | 0.0004 | 1 | 1 |
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one) | Homo sapiens (human) | IC50 | 0.5100 | 1 | 1 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
pd 184352 | Homo sapiens (human) | EC50 | 0.1000 | 1 | 1 |
cx 4945 | Homo sapiens (human) | EC50 | 3.1500 | 2 | 2 |
[no title available]Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.Bioorganic & medicinal chemistry, , Feb-15, Volume: 17, Issue:4, 2009
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.Proceedings of the National Academy of Sciences of the United States of America, , Dec-18, Volume: 104, Issue:51, 2007
[no title available]Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.Bioorganic & medicinal chemistry, , 03-01, Volume: 27, Issue:5, 2019
[no title available]Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility.Journal of natural products, , 04-26, Volume: 82, Issue:4, 2019
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy.Journal of medicinal chemistry, , 12-23, Volume: 64, Issue:24, 2021
[no title available]Journal of medicinal chemistry, , 04-22, Volume: 64, Issue:8, 2021
New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.ACS medicinal chemistry letters, , May-14, Volume: 11, Issue:5, 2020
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.Journal of medicinal chemistry, , 02-28, Volume: 62, Issue:4, 2019
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.Journal of medicinal chemistry, , 11-21, Volume: 61, Issue:22, 2018
Enables
This protein enables 4 target(s):
Target | Category | Definition |
protein serine/threonine kinase activity | molecular function | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. [GOC:bf, MetaCyc:PROTEIN-KINASE-RXN, PMID:2956925] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
ATP binding | molecular function | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732] |
protein serine kinase activity | molecular function | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. [RHEA:17989] |
Located In
This protein is located in 1 target(s):
Target | Category | Definition |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
protein kinase CK2 complex | cellular component | A protein complex that possesses protein serine/threonine kinase activity, and contains two catalytic alpha subunits and two regulatory beta subunits. Protein kinase CK2 complexes are found in nearly every subcellular compartment, and can phosphorylate many protein substrates in addition to casein. [GOC:mah, PMID:10994779] |
Involved In
This protein is involved in 7 target(s):
Target | Category | Definition |
protein phosphorylation | biological process | The process of introducing a phosphate group on to a protein. [GOC:hb] |
positive regulation of cell population proliferation | biological process | Any process that activates or increases the rate or extent of cell proliferation. [GOC:go_curators] |
positive regulation of cell growth | biological process | Any process that activates or increases the frequency, rate, extent or direction of cell growth. [GOC:go_curators] |
positive regulation of protein catabolic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. [GOC:go_curators] |
peptidyl-threonine phosphorylation | biological process | The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. [RESID:AA0038] |
peptidyl-serine phosphorylation | biological process | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. [RESID:AA0037] |
regulation of cell cycle | biological process | Any process that modulates the rate or extent of progression through the cell cycle. [GOC:ai, GOC:dph, GOC:tb] |